Topics: Eating Disorders | Practice Tools and Tips | Psychopharmacology Tips | Psychotherapy

In January of this year, the FDA approved the stimulant lisdexamfetamine (Vyvanse) as the first drug with an indication for binge eating disorder (BED). Patients are hearing the buzz and may be asking you to prescribe it, but you may have some questions first.

Dr. Lock outlines a treatment method for anorexia nervosa that helps family members better understand the disorder and enlists their help in providing a home environment based on successful inpatient services for weight restoration.

Topics: Antipsychotics | Psychopharmacology Tips | Research Updates

Patients with schizophrenia often stop taking their medications, so long-acting injectable antipsychotics (LAIs) are potentially good ways to make sure these patients have some medication in their systems over the long term.